Skip Navigation

Patent Detail: Sorafenib Derivatives as P21 Inhibitors

Patent Detail

Superfund Research Program

Sorafenib Derivatives as P21 Inhibitors

Number: 10,449,1882
Year: 2019
Patent Status: Issued
Authors: Weiss, R.H., B.D. Hammock, H. Inoue, S.H. Hwang

Associated Projects:

  • University of California-Davis: Development and Application of Integrated In Vitro and Cell-Based Bioassays
  • University of California-Davis: Analytical Chemistry Core
Back
to Top